Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis

J Gastrointestin Liver Dis. 2022 Dec 17;31(4):478-479. doi: 10.15403/jgld-4599.
No abstract available

Publication types

  • Letter

MeSH terms

  • Colitis, Ulcerative* / drug therapy
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Treatment Outcome
  • Ustekinumab / therapeutic use

Substances

  • Ustekinumab
  • Gastrointestinal Agents
  • Infliximab